Postsurgical Outcomes of Mesial Temporal Lobe Epilepsy due to Hippocampal Sclerosis Associated with Calcified Neurocysticercosis

被引:1
|
作者
De la Cruz, Walter [1 ]
Sanchez-Boluarte, Sofia S. [1 ,2 ]
Chacon, Denisse E. [1 ]
Herrera, Manuel [3 ]
del Prado, Liza Nunez [1 ]
Vasquez, Carlos M. [4 ]
Delgado, Jose C. [1 ]
机构
[1] Inst Nacl Ciencias Neurol, Epilepsy Dept, Lima, Peru
[2] Univ Cesar Vallejo, Sch Med, Trujillo, Peru
[3] McMaster Univ, Dept Med, Hamilton, ON, Canada
[4] Inst Nacl Ciencias Neurol, Neurosurg Dept, Lima, Peru
关键词
DRUG-RESISTANT EPILEPSY; INTRACTABLE EPILEPSY; SURGICAL-TREATMENT; ILAE COMMISSION; TASK-FORCE; LESIONS; EPILEPTOGENESIS; SEIZURES; SURGERY; SERUM;
D O I
10.4269/ajtmh.23-0506
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to analyze postsurgical outcomes for individuals with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) who underwent anterior temporal lobectomy, based on the presence of calcified neurocysticercosis (cNCC). A retrospective cross-sectional study was conducted on 89 patients with MTLE-HS who underwent anterior temporal lobectomy between January 2012 and December 2020 at a basic epilepsy surgery center located in Lima, Peru. We collected sociodemographic, clinical, and diagnostic information. The postsurgical results were analyzed using bivariate analysis according to the Engel classification. We included 89 individuals with a median age of 28 years (interquartile range [IQR]: 24-37), and more than half (55.1%) were male. Seventeen (19.1%) were diagnosed with cNCC. A greater number of patients with cNCC had lived in rural areas of Peru during their early life compared with those without cNCC (12 [70.6%] versus 26 [36.1%]; P = 0.010). Patients with cNCC exhibited a greater median frequency of focal to bilateral tonic-clonic seizures per month (1 [IQR: 0-2] versus 0 [0-0.5]; P = 0.009). Conversely, a lower proportion of patients with cNCC reported a history of an initial precipitating injury in comparison to the group without cNCC (4 [23.5%] versus 42 [58.3%]; P = 0.014). At the 1-year follow-up, most patients (82.4%) with cNCC were categorized as Engel IA. Similarly, at the 2-year follow-up, nine (75.0%) were classified as Engel IA. Our findings suggest that most patients diagnosed with cNCC exhibit favorable postsurgical outcomes, comparable to those without cNCC. Additionally, it can be postulated that cNCC may play a role as an initial precipitating injury.
引用
收藏
页码:700 / 705
页数:6
相关论文
共 50 条
  • [41] Auras in patients with temporal lobe epilepsy and mesial temporal sclerosis
    Asadi-Pooya, Ali A.
    Nei, Maromi
    Sharan, Ashwini
    Sperling, Michael R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 364 : 24 - 26
  • [42] Radiosurgery for Medial Temporal Lobe Epilepsy Resulting from Mesial Temporal Sclerosis
    Gianaris, Thomas
    Witt, Thomas
    Barbaro, Nicholas M.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2016, 27 (01) : 79 - +
  • [43] Amygdala enlargement occurs in patients with mesial temporal lobe epilepsy and hippocampal sclerosis with early epilepsy onset
    Coan, Ana C.
    Morita, Marcia E.
    Campos, Brunno M.
    Bergo, Felipe P. G.
    Kubota, Bruno Y.
    Cendes, Fernando
    EPILEPSY & BEHAVIOR, 2013, 29 (02) : 390 - 394
  • [44] Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy
    Filimonova, Elena A.
    Pashkov, Anton A.
    Moysak, Galina I.
    Tropynina, Anastasia Y.
    Zhanaeva, Svetlana Y.
    Shvaikovskaya, Anna A.
    Akopyan, Anna A.
    Danilenko, Konstantin V.
    Aftanas, Lyubomir I.
    Tikhonova, Maria A.
    Rzaev, Jamil A.
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [45] Failed epilepsy surgery for mesial temporal lobe sclerosis: a review of the pathophysiology
    Vale, Fernando L.
    Pollock, Glen
    Benbadis, Selim R.
    NEUROSURGICAL FOCUS, 2012, 32 (03)
  • [46] Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis
    Pohlen, Michael S.
    Jin, Jingxiao
    Tobias, Ronnie S.
    Maheshwari, Atul
    EPILEPSY RESEARCH, 2017, 137 : 56 - 60
  • [47] Preoperative depressive symptoms are not predictors of postoperative seizure control in patients with mesial temporal lobe epilepsy and hippocampal sclerosis
    Lackmayer, Katharina
    Lehner-Baumgartner, Eva
    Pirker, Susanne
    Czech, Thomas
    Baumgartner, Christoph
    EPILEPSY & BEHAVIOR, 2013, 26 (01) : 81 - 86
  • [48] Deep brain stimulation of the subiculum in the treatment for refractory temporal lobe epilepsy due to unilateral mesial temporal lobe sclerosis
    Sobstyl, Micha l
    Kowalska, Magdalena
    Konopko, Magdalena
    Wierzbicka, Aleksandra
    Karamon, Karol
    Naganska, Ewa
    EPILEPSY & BEHAVIOR REPORTS, 2024, 27
  • [49] Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis
    Carton, Robert J.
    Doyle, Michael G.
    Kearney, Hugh
    Steward, Charles A.
    Lench, Nicholas J.
    Rogers, Anthony
    Heinzen, Erin L.
    McDonald, Seamus
    Fay, Joanna
    Lacey, Austin
    Beausang, Alan
    Cryan, Jane
    Brett, Francesca
    El-Naggar, Hany
    Widdess-Walsh, Peter
    Costello, Daniel
    Kilbride, Ronan
    Doherty, Colin P.
    Sweeney, Kieron J.
    O'Brien, Donncha F.
    Henshall, David C.
    Delanty, Norman
    Cavalleri, Gianpiero L.
    Benson, Katherine A.
    EPILEPSIA, 2024, 65 (05) : 1451 - 1461
  • [50] MicroRNAs as potential biomarkers in temporal lobe epilepsy and mesial temporal lobe epilepsy
    Martinez, Bridget
    Peplow, Philip V.
    NEURAL REGENERATION RESEARCH, 2023, 18 (04) : 716 - 726